Intellia Therapeutics
NTLA
NTLA
271 hedge funds and large institutions have $923M invested in Intellia Therapeutics in 2025 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 107 increasing their positions, 86 reducing their positions, and 53 closing their positions.
Holders
271
Holders Change
-21
Holders Change %
-7.19%
% of All Funds
3.64%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
40
Increased
107
Reduced
86
Closed
53
Calls
$16M
Puts
$9.68M
Net Calls
+$6.32M
Net Calls Change
+$5.71M
Top Buyers
| 1 |
BBA
1
Baker Bros. Advisors
New York
|
$25.1M |
| 2 |
WP
2
Woodline Partners
San Francisco,
California
|
$11.4M |
| 3 |
3
D.E. Shaw & Co
New York
|
$7.74M |
| 4 |
4
Renaissance Technologies
New York
|
$6.35M |
| 5 |
MG
5
Marex Group
London,
|
$5.85M |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
326
Wolverine Trading
Chicago,
Illinois
| – | – | – | – |
|
327
Nomura Asset Management
Tokyo,
Japan
| – | – | – | – |
|